Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-03-03 @ 3:03 PM
Study NCT ID:
NCT01064518
Status:
COMPLETED
Last Update Posted:
2020-08-28
First Post:
2010-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Sponsor:
Revance Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-04
First Submit QC Date:
None
Study First Post Date:
2010-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-06-27
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-08-20
Last Update Post Date:
2020-08-28
Last Update Post Date Type:
ACTUAL